Seeking Alpha

Pluristem Therapeutics (PSTI +4.2%) enjoys continued upward momentum after Thursday's news that...

Pluristem Therapeutics (PSTI +4.2%) enjoys continued upward momentum after Thursday's news that it received permission from India's health ministry to proceed with a Phase II clinical trial for the treatment of Buerger's disease. The trial could be followed by a larger multi-national Phase III. Shares popped 10% yesterday on the announcement.
Comments (3)
  • mossman
    , contributor
    Comments (8) | Send Message
     
    Company seems possibly great stock is scary great is it just mo or is something coming soon that warrants this price action with this huge volumes
    17 Aug 2012, 12:37 PM Reply Like
  • mikem1111
    , contributor
    Comments (22) | Send Message
     
    I am an aggressive, middle age investor. I live in both Nashville and Israel.

     

    PSTI is an exciting company with huge possibilities. I totally agree with Scott Matusow that PSTI and ATRS are retirement quality stocks.
    19 Aug 2012, 04:13 PM Reply Like
  • mossman
    , contributor
    Comments (8) | Send Message
     
    Friday looked like a classic rig job considering volumes and how it traded! Watch out, I sold all my stocks! Way down I'm a buyer if it continues to pick up industry support!
    20 Aug 2012, 09:51 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs